2-((4-Methyl-6-oxo-6H-benzo[c]chromen-3-yl)oxy)acetic acid

Catalog No. :
ACVKPR712
CAS No. :
302551-56-0
Molecular Formula :
C16H12O5
Molecular Weight :
284.27

IUPAC Name:2-((4-methyl-6-oxo-6H-benzo[c]chromen-3-yl)oxy)acetic acid

2-((4-Methyl-6-oxo-6H-benzo[c]chromen-3-yl)oxy)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$310.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Methyl-6-oxo-6H-benzo[c]chromen-3-yl)oxy)acetic acid
IUPAC Name2-((4-methyl-6-oxo-6H-benzo[c]chromen-3-yl)oxy)acetic acid
MDL No.MFCD01847438
Molecular FormulaC16H12O5
Molecular Weight284.27
SMILESO=C(O)COC1=C(C)C(O2)=C(C=C1)C3=CC=CC=C3C2=O
InChI KeyWADNBVMGEJFFIZ-UHFFFAOYSA-N
Synonym(4-METHYL-6-OXO-6H-BENZO[C]CHROMEN-3-YLOXY)-ACETIC ACID;2-(4-methyl-6-oxo-benzo[c]isochromen-3-yl)oxyacetic acid;2-(4-methyl-6-oxobenzo[c]isochromen-3-yl)oxyacetic acid;2-(4-methyl-6-oxo-benzo[c]isochromen-3-yl)oxyethanoic acid;2-(6-keto-4-methyl-benzo[c]isochromen-3-yl)oxyacetic acid;2-[(4-methyl-6-oxo-3-benzo[c]isochromenyl)oxy]acetic acid;BIM-0003116.P001;CBMicro_003037
CAS No.302551-56-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACVKPR712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVKPR712 route product structure diagram
    ACVKPR712302551-56-0
Inquiry

2. ACVKPR712 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVKPR712 route product structure diagram
    ACVKPR712302551-56-0
Inquiry

Comments (0)